TY  - JOUR
T1  - Norstictic Acid Inhibits the Growth of Murine SV40 Transformed Lymphoid Carcinoma 
  Cells <I>In vitro</I>
AU - I.E. Affeam, Bangolah AU - L.N. Alloula, Shellaleh AU - O.Q. Semeyannah, Accomodo 
JO  - Research Journal of Pharmacology
VL  - 7
IS  - 3
SP  - 26
EP  - 28
PY  - 2013
DA  - 2001/08/19
SN  - 1815-9362
DO  - rjpharm.2013.26.28
UR  - https://makhillpublications.co/view-article.php?doi=rjpharm.2013.26.28
KW  - Norstictic acid
KW  -cancer
KW  -growth
KW  -radiotherapy
KW  -in vitro
KW  -Buellia zahlbruckneri
AB  - Researchers test the effects of Norstictic acid, secondary 
  metabolite of the lichen <I>Buellia zahlbruckneri</I>, on the growth of murine 
  SV40 transformed lymphoid carcinoma cells <I>in vitro</I>. Researchers find 
  that Norstictic acid is a potent inhibitor of growth. Researchers, also find 
  that Norstictic acid increases sensitivity of cells to radiation and this effect 
  is significant at a radiation intensity lower than the standard intensity of 
  cancer radiotherapy. On the basis of this study, Norstictic acid shows promise 
  for combined-modality cancer treatment.
ER  -